Investments
 |
Acadia Pharmaceuticals San Diego, US Small molecules for CNS disorders. |
 |
Albireo Gothenburg, Sweden Small molecules for gastrointestinal diseases (AstraZeneca spin out). |
 |
Altus Pharmaceuticals Boston, US Protein therapeutics for metabolic diseases (Vertex spin-out). |
 |
Arakis (acquired by Sosei) Oxford, UK Reprofiled molecules for inflammatory and respiratory diseases. |
 |
Ark Therapeutics London, UK Gene therapy for oncology and haematology. |
 |
ARYx Therapeutics San Francisco, US Safer drugs through retrometabolic engineering. |
 |
Atani Tokyo, Japan Developing western drugs for the Japanese market. |
 |
Avant Immunotherapeutics Boston, US Small molecules for the manipulation of the immune system. |
 |
Cerimon Pharmaceuticals San Francisco, US Therapies for pain, autoimmune and inflammatory disease. |
 |
Chroma Therapeutics Oxford, UK Small molecules for oncology and inflammation. |
 |
Contec Medical Israel Medical imaging device for diagnosis and surgery. |
 |
DeveloGen (acquired by Evotec) Goettingen, Germany Peptides and small molecules for metabolic diseases. |
 |
DrugAbuse Sciences (acquired by Elbion) Paris, France Small molecules for the treatment of addictions. |
 |
Idenix Boston, US Small molecules for Hepatitis B and C. |
 |
Immgenics (acquired by Abgenix – now Amgen) Vancouver, Canada Antibody selection technology. |
 |
Intercell Vienna, Austria Vaccines for bacterial and viral infections. |
 |
Morphochem (acquired by Biovertis) Munich, Germany Small molecule anti-infectives and anti-coagulants. |
 |
Nabriva Therapeutics Vienna, Austria Small molecules for bacterial infections (Sandoz spin-out). |
 |
OmniSonics Medical Technologies Boston, US Device for clearance of occluded blood vessels. |
 |
OncoMed Pharmaceuticals San Francisco, US Developing antibodies to cancer stem cells. |
 |
Paratek Pharmaceuticals Boston, US Small molecules for bacterial infections. |
 |
Pharmion (acquired by Celgene) Boulder, US Small molecules for oncology and haematology. |
 |
Phenomix San Diego, US Small molecules for Type 2 diabetes and Hepatitis C. |
 |
Proteolix (acquired by Onyx Pharmaceuticals) San Francisco, US Therapies targeting the proteasome to treat oncology and autoimmune diseases. |
 |
Sequenom San Diego, US Diagnostics for rapid genetic analysis. |
 |
Targacept Winston-Salem, US Small molecules for CNS conditions. |
 |
Viacell (acquired by PerkinElmer) Boston, US Cord blood banking and cell therapies. |
 |
Weston Medical Stradbroke, UK Needle free drug delivery. |
 |
Zosano Pharma San Francisco, US Transdermal drug delivery technology (Alza/J&J spin-out). |